Polar Capital Hits Record £26.7bn Assets Under Management in Interim Results

My take: the inflection in Q2 matters more than the half-year total. If that trend holds, Polar should move back towards net inflows, especially with a richer US distribution push.

Performance scorecard: winners, laggards and dispersion

Several strategies delivered strongly: Global Technology, the Technology Trust and the Artificial Intelligence Fund rebounded after a weak first quarter; Healthcare Opportunities and Biotechnology outperformed; Smart Energy and Convertibles also posted good results.

On the flip side, Emerging Markets Stars lagged given a China underweight and stock‑specific issues. Within Financials, the Global Financials Trust underperformed, though the Financial Credit Fund beat its benchmark. Several European regional and single‑country strategies trailed, with Polar Capital Japan Fund the exception.

Across UCITS funds, 68% of AuM sits in the top two peer‑group quartiles over one year, 67% over three years, 85% over five years and 100% since inception. That depth helps sales teams, but dispersion in markets increases the risk of near‑term reversals.

Earnings quality and margins: what’s behind the PBT rise

Profit before tax rose 21% to £27.9m, but the cleaner lens is core operating profit, down 8% to £25.1m. Net management fees were broadly flat at £86.8m despite higher average AuM, as the fee yield slipped 3 bps to 75 bps due to mix, fee changes on the Technology Trust and a weaker US dollar.

Total operating costs fell 6% to £63.4m because last year had impairment charges. Strip those out and underlying costs were up 3%, driven by higher share‑based payments and investment in US marketing and digital content. The core operating margin edged down to 29% from 31% – not alarming, but worth watching if fee pressure persists.

Investment trusts: continuation secured, tender executed

Polar’s trusts are roughly one quarter of group AuM and remain strategically important. The Global Financials Trust completed a scheduled tender, returning £280m and restarting a five‑year term with net assets of £360m. The Technology Trust secured an overwhelming continuation vote, with about 99% in favour. The Global Healthcare Trust has a scheduled tender planned for early December 2025, subject to approval.

Opinion: governance discipline through tenders can crimp AuM in the short run but helps long‑term credibility, especially when discounts bite. Continuation votes going through smoothly are a relief.

Dividend, balance sheet and buybacks

The Board declared an interim dividend of 14.0p, payable on 9 January 2026, with an ex‑dividend date of 11 December and record date of 12 December. That equates to a 77% payout of first‑half adjusted diluted core EPS, signalling confidence in earnings resilience.

Cash and cash equivalents were £82.5m at period end (down from £121.8m in March) after paying £30.9m of dividends and purchasing £3.0m of own shares. Net assets stood at £126.2m versus £134.4m at March. The balance sheet remains solid for a boutique manager.

Client base and distribution runway

The investor mix is still UK‑heavy at 61% of AuM, with Europe at 26%, Asia 6%, Nordics 4% and North America 2%. Management is targeting a “step‑change” in the US while building on Asia. If executed, that could diversify flows and reduce reliance on UK retail and European wholesale channels.

What to watch next

• Net flows in Q3 and Q4 – does the Q2 improvement persist and flip to net inflows?
• Fee yield – can Polar defend the 75 bps management fee margin as mix shifts and FX moves?
• Technology concentration – with tech now 51% of AuM, market reversals would bite revenues.
• Trust activity – outcome of the Global Healthcare Trust tender and discount management across the trust range.
• US distribution – early evidence that investment in US marketing converts pipeline into durable mandates.

Josh’s view: a good half masked by mix effects

This is a solid set of interims. Record AuM, a strong bounce in technology strategies and visible improvement in flows through the quarter are all clear positives. The dividend is held at 14.0p, backed by cash and a sturdy balance sheet.

The nits to pick: fee margin drift, an 8% drop in core operating profit and continued outflows in Healthcare, Europe and Emerging Markets. None of that is fatal, but it underscores why management is leaning into distribution and targeted fixes. With AuM already £28.4bn post period‑end and enthusiasm for AI still supportive, Polar has the wind at its back – it now needs to convert interest into consistent net inflows while keeping tight control of costs.

Bottom line: momentum is improving, the platform is scalable and the brand remains strong. If flows turn positive and margins stabilise, there’s scope for earnings to compound from here.